Search
  • Search
Ireland: Tenders/St James's Hospital/Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

  1. Competition notice published

    Oct 20, 7:52 AMOctober 20, 2026 7:52 AM

  2. Questions deadline

    Nov 12, 3:00 PMNovember 12, 2026 3:00 PM

  3. Tender submission deadline

    Nov 19, 11:00 AMNovember 19, 2026 11:00 AM

  4. Opening date

    Nov 19, 11:30 AMNovember 19, 2026 11:30 AM

  5. Tender validity period

    Mar 19, 2027 11:00 AMMarch 19, 2027 11:00 AM

Brief

Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

Deadline
Nov 19,Questions by Nov 12,
Procedure
OpenSingle stage
Agreement
Buying goods
Estimated value
€375Kover 5 years

Brief

St James's Hospital needs Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department in Dublin for a maximum total value of 375,000 EUR over 60 months. The reagents and consumables are required to continue providing legacy clonality testing using capillary electrophoresis, while the laboratory develops Next Generation Sequencing (NGS) based testing methodologies.

Laboratorie- og analyseutstyr

Register interest

Custom Assessment Criteria

  • Get answers to your bid/no-bid criteria

    Set them up once and Cobrief answers them in every tender

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at St James's Hospital

From the notice

  • The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancy. Currently this testing is divided among standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. While the laboratory is developing NGS based testing methodologies it is also seeking to secure access to reagents and consumables to continue to provide legacy clonality testing using capillary electrophoresis.

  • Contact

    Pat Sullivandgunning@stjames.ie
  • Type
    Competition
  • Location
    Dublin
  • Main code
    Laboratory, optical and precision equipments (excl. glasses)
    38000000
  • 33696500Laboratory reagents33696600Reagents for electrophoresis

Similar active competitions

  • St James's Hospital

    Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

    St James's Hospital needs a digital PCR platform, including all hardware, software, and ancillary equipment, along with associated reagents and support, for its Cancer Molecular Diagnostics Department in Dublin. The contract duration is 54 months, with a maximum total value of 250,000 EUR. The purchase includes a minimum three-year comprehensive warranty, installation, commissioning, and training. The platform will be used for assay development, evaluation, and method transfer, with an agreed quantity/value of development reagents and consumables to be drawn down over the three-year agreement.

    Competition
    Nov 10, 2026(3 days)
    €250,000

  • St James's Hospital

    Helse- og sosial tjenesteyting

    Provision of GP services to Ward A SJH Transitional Care Unit Based in St Luke's Hospital Rathgar and Hollybrook Lodge Residential Care for St. James’s Hospital

    St James's Hospital needs GP services for Ward A SJH Transitional Care Unit in St Luke's Hospital Rathgar and Hollybrook Lodge Residential Care for St. James’s Hospital in Dublin. The contract has a maximum total value of 1,000,000 EUR over 4 years.

    Competition
    Nov 19, 2026(12 days)
    €1,000,000

  • Sykehusinnkjøp Hf

    Medisinsk og laboratorieutstyr

    NGS sekvenseringsplattform til avd. for patologi ved St. Olavs hospital HF

    Sykehusinnkjøp Hf planlegger anskaffelsen av en helautomatisert NGS-sekvenseringsplattform for avdeling for patologi ved St. Olavs hospital HF, som skal utvide og videreutvikle dagens analysekapasitet for klinisk diagnostikk av DNA og RNA fra FFPE-prøver og ctDNA. Løsningen skal være en samlet plattform som håndterer hele prosessen fra bibliotekspreparering til sekvensering, bioinformatisk analyse og rapportering, og skal være tilgjengelig med CE-IVD/IVDR-godkjente paneler der dette foreligger. Thermo Fisher Diagnostics AS har sannsynligvis kontrakten i dag.

    Planning
    Feb 1, 2027(86 days)
    NOK 0